Back to Search
ZOLTAN HORVATH, M.D.
M.D.
Critical Care Medicine (Anesthesiology) Physician
NPI: 1770753782IndividualAccepts Medicare
Specialties, Licenses & Credentials
Critical Care Medicine (Anesthesiology) PhysicianPrimary
Anesthesiology — Critical Care Medicine
Code: 207LC0200X
9191(NV)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
OTHER
Class of 1986
Research & Publications (20)
Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells.
PMID 18841326·Invest New Drugs·2009
8-other
Policy options for obesity in Europe: a comparison of public health specialists with other stakeholders.
PMID 18662488·Public Health Nutr·2009
4-observational
Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
PMID 18023527·Cancer Lett·2008
8-other
Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.
PMID 18813804·Int J Oncol·2008
8-other
Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity.
PMID 18497974·Oncol Rep·2008
8-other
Acute renal failure, sensory aphasia and disorientation--a surprising diagnosis through renal biopsy.
PMID 17971382·Nephrol Dial Transplant·2008
5-case
Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.
PMID 16488533·Cancer Lett·2007
8-other
Changes in open-field activity and novelty-seeking behavior in periadolescent rats neonatally treated with monosodium glutamate.
PMID 17967732·Neurotox Res·2007
7-preclinical
N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.
PMID 17912455·Int J Oncol·2007
8-other
Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase.
PMID 17224405·Neuron·2007
7-preclinical
Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells.
PMID 17137710·Cancer Lett·2007
8-other
Association of polymorphisms in the dopamine D4 receptor gene and the activity-impulsivity endophenotype in dogs.
PMID 17986156·Anim Genet·2007
7-preclinical
A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon.
PMID 16525039·J Neurosci·2006
4-observational
Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
PMID 17065057·Nucleosides Nucleotides Nucleic Acids·2006
8-other
Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.
PMID 17065056·Nucleosides Nucleotides Nucleic Acids·2006
8-other
Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
PMID 16982330·Exp Hematol·2006
8-other
Effects of systemic PACAP treatment in monosodium glutamate-induced behavioral changes and retinal degeneration.
PMID 16888193·Ann N Y Acad Sci·2006
7-preclinical
Antitumor activity of C-methyl-beta-D-ribofuranosyladenine nucleoside ribonucleotide reductase inhibitors.
PMID 16033277·J Med Chem·2005
8-other
Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells.
PMID 15927674·Leuk Res·2005
8-other
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship.
PMID 15748702·Biochem Pharmacol·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3230 E FLAMINGO RD, 334
LAS VEGAS, NV 89121 - Phone
- (702) 454-8236
Quick Facts
- NPI
- 1770753782
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 20
Are you this provider?
Claim Your Profile